Cartesian Therapeutics Inc (RNAC)
CapEx to Revenue
0.00%
Quarterly · Period ending:
RNAC CapEx to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
RNAC Quarterly CapEx/Revenue (11.90% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
RNAC capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0% | |
| 34.6154% | |
| 51.9535% | |
| 285.8407% | |
| 870.8054% | |
| 97.7273% | |
| -92.8854% | |
| 1,601.8088% | |
| 4.7451% | |
| 10.3082% | |
| 0.7743% | |
| 0% | |
| 0.2286% | |
| 2.1893% | |
| 1.2563% | |
| 2.1053% | |
| 0.2521% | |
| 1.3383% | |
| 0.9286% | |
| 0.6714% | |
| 3.143% | |
| 0.2262% | |
| 1.5898% | |
| 6.2635% | |
| 0% | |
| 0% | |
| 0.5561% | |
| 0% | |
| 38.4615% | |
| 0% | |
| 40.753% | |
| 0% | |
| 0% | |
| 0% | |
| 876.4706% | |
| 462.963% | |
| 1,542.3077% | |
| 42.3358% | |
| 3.686% | |
| 26.3359% | |
| 2.9251% | |
| 6.8487% | |
| 6.1856% | |
| 29.7449% | |
| 34.7896% | |
| 11.8956% |